(AIR) Airbus SE - Overview
Exchange: PA •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0000235190
Stock:
Total Rating 47
Risk 75
Buy Signal -0.86
| Risk 5d forecast | |
|---|---|
| Volatility | 27.1% |
| Relative Tail Risk | -5.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.31 |
| Alpha | -1.57 |
| Character TTM | |
|---|---|
| Beta | 0.726 |
| Beta Downside | 1.078 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.54% |
| CAGR/Max DD | 0.67 |
EPS (Earnings per Share)
Revenue
Description: AIR Airbus SE
Airbus SE, together with its subsidiaries, engages in the design, manufacture, and delivery of aeronautics and aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft, freighter aircraft, regional turboprop aircraft, and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment develops, manufactures, markets, and sells civil and military helicopters; and provides uncrewed aerial systems and their related services. The Airbus Defence and Space segment designs, develops, delivers, and supports crewed and uncrewed military air systems and related services. This segment also offers civil and defence space systems for telecommunications, earth observations, navigation, and science and orbital systems; and services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. The company was incorporated in 1998 and is headquartered in Leiden, the Netherlands.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 5.22b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.04 > 1.0 |
| NWC/Revenue: 12.90% < 20% (prev 12.72%; Δ 0.18% < -1%) |
| CFO/TA 0.06 > 3% & CFO 8.01b > Net Income 5.22b |
| Net Debt (2.17b) to EBITDA (9.49b): 0.23 < 3 |
| Current Ratio: 1.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (790.9m) vs 12m ago 0.00% < -2% |
| Gross Margin: 14.94% > 18% (prev 0.15%; Δ 1478 % > 0.5%) |
| Asset Turnover: 55.59% > 50% (prev 53.58%; Δ 2.01% > 0%) |
| Interest Coverage Ratio: 8.26 > 6 (EBITDA TTM 9.49b / Interest Expense TTM 770.0m) |
Altman Z'' 1.55
| A: 0.07 (Total Current Assets 72.90b - Total Current Liabilities 63.43b) / Total Assets 134.94b |
| B: 0.17 (Retained Earnings 22.33b / Total Assets 134.94b) |
| C: 0.05 (EBIT TTM 6.36b / Avg Total Assets 132.08b) |
| D: 0.21 (Book Value of Equity 23.06b / Total Liabilities 108.75b) |
| Altman-Z'' Score: 1.55 = BB |
Beneish M -2.74
| DSRI: 1.31 (Receivables 10.99b/7.93b, Revenue 73.42b/69.23b) |
| GMI: 1.03 (GM 14.94% / 15.42%) |
| AQI: 0.97 (AQ_t 0.30 / AQ_t-1 0.31) |
| SGI: 1.06 (Revenue 73.42b / 69.23b) |
| TATA: -0.02 (NI 5.22b - CFO 8.01b) / TA 134.94b) |
| Beneish M-Score: -2.74 (Cap -4..+1) = A |
What is the price of AIR shares?
As of February 28, 2026, the stock is trading at EUR 184.24 with a total of 1,582,757 shares traded.
Over the past week, the price has changed by -2.90%, over one month by -7.60%, over three months by -9.89% and over the past year by +14.14%.
Over the past week, the price has changed by -2.90%, over one month by -7.60%, over three months by -9.89% and over the past year by +14.14%.
Is AIR a buy, sell or hold?
Airbus SE has no consensus analysts rating.
What are the forecasts/targets for the AIR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 217.2 | 17.9% |
| Analysts Target Price | - | - |
AIR Fundamental Data Overview February 25, 2026
Market Cap USD = 171.84b (145.23b EUR * 1.1832 EUR.USD)
P/E Trailing = 28.7919
P/E Forward = 24.9377
P/S = 1.9781
P/B = 6.9494
P/EG = 1.1757
Revenue TTM = 73.42b EUR
EBIT TTM = 6.36b EUR
EBITDA TTM = 9.49b EUR
Long Term Debt = 10.63b EUR (from longTermDebt, last quarter)
Short Term Debt = 5.19b EUR (from shortTermDebt, last quarter)
Debt = 16.30b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.17b EUR (from netDebt column, last quarter)
Enterprise Value = 154.79b EUR (145.23b + Debt 16.30b - CCE 6.74b)
Interest Coverage Ratio = 8.26 (Ebit TTM 6.36b / Interest Expense TTM 770.0m)
EV/FCF = 38.26x (Enterprise Value 154.79b / FCF TTM 4.05b)
FCF Yield = 2.61% (FCF TTM 4.05b / Enterprise Value 154.79b)
FCF Margin = 5.51% (FCF TTM 4.05b / Revenue TTM 73.42b)
Net Margin = 7.11% (Net Income TTM 5.22b / Revenue TTM 73.42b)
Gross Margin = 14.94% ((Revenue TTM 73.42b - Cost of Revenue TTM 62.45b) / Revenue TTM)
Gross Margin QoQ = 14.59% (prev 16.42%)
Tobins Q-Ratio = 1.15 (Enterprise Value 154.79b / Total Assets 134.94b)
Interest Expense / Debt = 1.26% (Interest Expense 206.0m / Debt 16.30b)
Taxrate = 6.89% (180.0m / 2.61b)
NOPAT = 5.92b (EBIT 6.36b * (1 - 6.89%))
Current Ratio = 1.15 (Total Current Assets 72.90b / Total Current Liabilities 63.43b)
Debt / Equity = 0.62 (Debt 16.30b / totalStockholderEquity, last quarter 26.10b)
Debt / EBITDA = 0.23 (Net Debt 2.17b / EBITDA 9.49b)
Debt / FCF = 0.54 (Net Debt 2.17b / FCF TTM 4.05b)
Total Stockholder Equity = 24.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.95% (Net Income 5.22b / Total Assets 134.94b)
RoE = 21.22% (Net Income TTM 5.22b / Total Stockholder Equity 24.60b)
RoCE = 18.05% (EBIT 6.36b / Capital Employed (Equity 24.60b + L.T.Debt 10.63b))
RoIC = 18.69% (NOPAT 5.92b / Invested Capital 31.68b)
WACC = 7.84% (E(145.23b)/V(161.53b) * Re(8.59%) + D(16.30b)/V(161.53b) * Rd(1.26%) * (1-Tc(0.07)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.07%
[DCF] Terminal Value 80.12% ; FCFF base≈4.00b ; Y1≈4.44b ; Y5≈5.81b
[DCF] Fair Price = 128.3 (EV 103.43b - Net Debt 2.17b = Equity 101.26b / Shares 789.4m; r=7.84% [WACC]; 5y FCF grow 12.80% → 2.90% )
EPS Correlation: 26.22 | EPS CAGR: 26.75% | SUE: 2.40 | # QB: 2
Revenue Correlation: 52.32 | Revenue CAGR: 22.88% | SUE: -0.96 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.69 | Chg7d=-1.072 | Chg30d=-1.092 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=7.42 | Chg7d=-0.369 | Chg30d=-0.405 | Revisions Net=-15 | Growth EPS=+7.7% | Growth Revenue=+10.5%
EPS next Year (2027-12-31): EPS=9.03 | Chg7d=-0.419 | Chg30d=-0.517 | Revisions Net=-10 | Growth EPS=+21.7% | Growth Revenue=+13.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 8.6% - Earnings Yield 3.5%)
[Growth] Growth Spread = -0.5% (Analyst 4.6% - Implied 5.1%)
P/E Trailing = 28.7919
P/E Forward = 24.9377
P/S = 1.9781
P/B = 6.9494
P/EG = 1.1757
Revenue TTM = 73.42b EUR
EBIT TTM = 6.36b EUR
EBITDA TTM = 9.49b EUR
Long Term Debt = 10.63b EUR (from longTermDebt, last quarter)
Short Term Debt = 5.19b EUR (from shortTermDebt, last quarter)
Debt = 16.30b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.17b EUR (from netDebt column, last quarter)
Enterprise Value = 154.79b EUR (145.23b + Debt 16.30b - CCE 6.74b)
Interest Coverage Ratio = 8.26 (Ebit TTM 6.36b / Interest Expense TTM 770.0m)
EV/FCF = 38.26x (Enterprise Value 154.79b / FCF TTM 4.05b)
FCF Yield = 2.61% (FCF TTM 4.05b / Enterprise Value 154.79b)
FCF Margin = 5.51% (FCF TTM 4.05b / Revenue TTM 73.42b)
Net Margin = 7.11% (Net Income TTM 5.22b / Revenue TTM 73.42b)
Gross Margin = 14.94% ((Revenue TTM 73.42b - Cost of Revenue TTM 62.45b) / Revenue TTM)
Gross Margin QoQ = 14.59% (prev 16.42%)
Tobins Q-Ratio = 1.15 (Enterprise Value 154.79b / Total Assets 134.94b)
Interest Expense / Debt = 1.26% (Interest Expense 206.0m / Debt 16.30b)
Taxrate = 6.89% (180.0m / 2.61b)
NOPAT = 5.92b (EBIT 6.36b * (1 - 6.89%))
Current Ratio = 1.15 (Total Current Assets 72.90b / Total Current Liabilities 63.43b)
Debt / Equity = 0.62 (Debt 16.30b / totalStockholderEquity, last quarter 26.10b)
Debt / EBITDA = 0.23 (Net Debt 2.17b / EBITDA 9.49b)
Debt / FCF = 0.54 (Net Debt 2.17b / FCF TTM 4.05b)
Total Stockholder Equity = 24.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.95% (Net Income 5.22b / Total Assets 134.94b)
RoE = 21.22% (Net Income TTM 5.22b / Total Stockholder Equity 24.60b)
RoCE = 18.05% (EBIT 6.36b / Capital Employed (Equity 24.60b + L.T.Debt 10.63b))
RoIC = 18.69% (NOPAT 5.92b / Invested Capital 31.68b)
WACC = 7.84% (E(145.23b)/V(161.53b) * Re(8.59%) + D(16.30b)/V(161.53b) * Rd(1.26%) * (1-Tc(0.07)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.07%
[DCF] Terminal Value 80.12% ; FCFF base≈4.00b ; Y1≈4.44b ; Y5≈5.81b
[DCF] Fair Price = 128.3 (EV 103.43b - Net Debt 2.17b = Equity 101.26b / Shares 789.4m; r=7.84% [WACC]; 5y FCF grow 12.80% → 2.90% )
EPS Correlation: 26.22 | EPS CAGR: 26.75% | SUE: 2.40 | # QB: 2
Revenue Correlation: 52.32 | Revenue CAGR: 22.88% | SUE: -0.96 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.69 | Chg7d=-1.072 | Chg30d=-1.092 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=7.42 | Chg7d=-0.369 | Chg30d=-0.405 | Revisions Net=-15 | Growth EPS=+7.7% | Growth Revenue=+10.5%
EPS next Year (2027-12-31): EPS=9.03 | Chg7d=-0.419 | Chg30d=-0.517 | Revisions Net=-10 | Growth EPS=+21.7% | Growth Revenue=+13.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 8.6% - Earnings Yield 3.5%)
[Growth] Growth Spread = -0.5% (Analyst 4.6% - Implied 5.1%)